Design and Synthesis of Novel Orally Selective and Type II Pan-Trk Inhibitors to Overcome Mutations by Property-Driven Optimization.
European Journal of Medicinal Chemistry（2021）
Key words
Tropomyosin receptor kinase (TRK),Kinase inhibitor,Fusion,Mutation,Property-driven optimization
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined